Mayo Genetic Risk Models for Newly Diagnosed Acute Myeloid Leukemia Treated With Venetoclax + Hypomethylating Agent
The Mayo genetic risk models offer pre-treatment and response-based prognostic tools for newly diagnosed AML treated with Ven-HMA.
The Mayo genetic risk models offer pre-treatment and response-based prognostic tools for newly diagnosed AML treated with Ven-HMA.
PURPOSEFinancial toxicity (FT) of cancer treatment likely affects more patients in low- and middle-income countries (LMICs); however, most of the research on FT comes from…
Nature Communications – Colorectal cancer has been linked to multiple environmental factors, however, the role of diet remains incompletely understood. Here, the authors complete a…
Jerry Springer died of pancreatic cancer, but only suffered shortly as his diagnosis came just ahead of his death. A new documentary gives fans a…
At the free, LIVE class, you’ll get everything you need to make your decision & upgrade your job in 2025, regardless if you stay or…
View all available purchase options and get full access to this article. The following represents disclosure information provided by the author of this manuscript. All…
Not satisfied with what he’s done to America, the world’s richest man is now looking to interfere in a European country.
Emergency cardiac care, cardiology, EKGs, ECGs, electrocardiography, echocardiography, dysrhythmias, arrhythmias, STEMI, NonSTEMI, NSTEMI, cardiology
Headlines warning people to throw out their black plastic kitchen utensils live on, as do social media posts warning of “secret toxins” in your kitchen.…
5 Articles in Immunotherapy suggested by Wafik El-Deiry / A. Ari Hakimi, Abhinav Pandey, Akshay J. Patel, Andrew Sangho Lee, Anuj Wali, Attila A. Seyhan,